Veracyte (NASDAQ: VCYT) reported Q2 EPS of ($0.12), $0.03 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $90.3 million versus the consensus estimate of $83.08 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.